Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes. In recent years, CAR-T cell therapies have become ...

In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

For 24 years, the Lymphoma, Leukemia & Myeloma Congress has stood as the premier educational conference dedicated to hematologic malignancies. Over 75 experts from around the globe gather in New ...

1 Multiple myeloma originates in blood plasma cells ... potentially drive cures for certain types of blood cancers, like lymphoma. 6-8 CAR-T therapies are a type of living drug that is created ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

For some types of cancer, risk factors are known for the majority of cases. For example, smoking causes most lung cancers. This provides an opportunity for prevention. With multiple myeloma, few cases ...

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...